Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Can a nasal spray give you tanner skin, better digestion, and a pep in your step? Medical professionals sniff out the truth ...
According to Jin, the Medicube PDRN Pink Peptide Serum fits flawlessly into any routine. Apply it after your favorite ...
Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines. Through its partnerships, the Genetic Medicines division is ...
Peptide-nucleic acids (PNAs) remain a promising therapeutic modality, although their success in the clinic remains modest compared to other nucleic acid–based products, such as thiophosphoryl and ...
A fundamental characteristic of gene mutations is the permanent alteration of the DNA sequence, including point mutations, deletions, inversions, and translocations. Among these, DNA point mutation ...
CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...
German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback